https://www.prnewswire.com/news-releases/heptares-and-takeda-initiate-drug-discovery-collaboration-focused-on-gpcr-linked-to-cns-disorders-119584024.html
/PRNewswire/ -- - Deal Includes GBP4.5 Million Upfront Cash and Equity, Up to GBP60.5 Million in Future Milestone Payments, and Royalties on Product Sales...
drug discoverytakedainitiatecollaborationfocused
https://eni.mh.tum.de/immune-glia/
The junior research group focuses on pathomechanisms of CNS disorders, aiming to identify glial-derived determinants of disease trajectories as potential...
cns disordersimmunegliainteractionseni